214 related articles for article (PubMed ID: 24923108)
21. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
22. [Antibodies against vaccine-preventable diseases in pregnant women and their offspring. Diphtheria, pertussis, tetanus].
Sauerbrei A; Prager J; Bischoff A; Wutzler P
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):16-20. PubMed ID: 15205819
[TBL] [Abstract][Full Text] [Related]
23. Diphtheria, tetanus, pertussis: antibody detection in New Zealand.
Lau RC
N Z Med J; 1987 Aug; 100(829):481-3. PubMed ID: 3502676
[TBL] [Abstract][Full Text] [Related]
24. Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection.
Yao N; Zeng Q; Wang Q
Public Health; 2018 Mar; 156():60-66. PubMed ID: 29408190
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of antibodies for pertussis and diphtheria among people leaving or entering China: a cross-sectional study.
Han H; Fang Z; Ye X; Wu H; Zuo F; Shi Q; Mu J; Xu B
J Infect Dev Ctries; 2019 May; 13(5):394-399. PubMed ID: 32053508
[TBL] [Abstract][Full Text] [Related]
26. An open-label, randomized, multicenter study of the safety, tolerability, and immunogenicity of quadrivalent human papillomavirus (types 6/11/16/18) vaccine given concomitantly with diphtheria, tetanus, pertussis, and poliomyelitis vaccine in healthy adolescents 11 to 17 years of age.
Vesikari T; Van Damme P; Lindblad N; Pfletschinger U; Radley D; Ryan D; Vuocolo S; Haupt RM; Guris D
Pediatr Infect Dis J; 2010 Apr; 29(4):314-8. PubMed ID: 19952980
[TBL] [Abstract][Full Text] [Related]
27. Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children.
Zarei S; Jeddi-Tehrani M; Akhondi MM; Zeraati H; Kheirkhah T; Ghazanfari M; Shokri F
Iran J Immunol; 2007 Jun; 4(2):101-9. PubMed ID: 17652850
[TBL] [Abstract][Full Text] [Related]
28. Seroprevalence of vaccine-preventable diseases among young children in the United Arab Emirates.
Al-Mekaini LA; Kamal SM; Al-Jabri O; Soliman M; Alshamsi H; Narchi H; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2016 Sep; 50():67-71. PubMed ID: 27457919
[TBL] [Abstract][Full Text] [Related]
29. The 1985 national immunisation survey: diphtheria, tetanus, and pertussis (whooping cough).
Lau RC; Bettelheim KA; Patel AC
N Z Med J; 1988 Nov; 101(858):797-800. PubMed ID: 3194078
[TBL] [Abstract][Full Text] [Related]
30. [Seroepidemiological Studies on Pertussis, Diphtheria and Tetanus among Nursing Students Enrolled between 1994 and 2011 in the Kitakyushu District].
Yamaguchi Y; Morokuma K; Meno Y; Okada K; Miyazaki C; Ueda K
Kansenshogaku Zasshi; 2016 Jul; 90(4):473-9. PubMed ID: 30212033
[TBL] [Abstract][Full Text] [Related]
31. Decennial administration of a reduced antigen content diphtheria and tetanus toxoids and acellular pertussis vaccine in young adults.
Mertsola J; Van Der Meeren O; He Q; Linko-Parvinen A; Ramakrishnan G; Mannermaa L; Soila M; Pulkkinen M; Jacquet JM
Clin Infect Dis; 2010 Sep; 51(6):656-62. PubMed ID: 20704493
[TBL] [Abstract][Full Text] [Related]
32. Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation.
Small TN; Zelenetz AD; Noy A; Rice RD; Trippett TM; Abrey L; Portlock CS; McCullagh EJ; Vanak JM; Mulligan AM; Moskowitz CH
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1538-42. PubMed ID: 19896077
[TBL] [Abstract][Full Text] [Related]
33. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
35. The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China.
Meng Q; Qian Q; Li L; Liu D; Gao W; Yuan L; Yao K
BMC Pediatr; 2019 Dec; 19(1):480. PubMed ID: 31810436
[TBL] [Abstract][Full Text] [Related]
36. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
Bernbaum J; Daft A; Samuelson J; Polin RA
Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women.
Halperin BA; Morris A; Mackinnon-Cameron D; Mutch J; Langley JM; McNeil SA; Macdougall D; Halperin SA
Clin Infect Dis; 2011 Nov; 53(9):885-92. PubMed ID: 21946190
[TBL] [Abstract][Full Text] [Related]
38. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey].
Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B
Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881
[TBL] [Abstract][Full Text] [Related]
39. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine.
Lin TY; Wang YH; Huang YC; Chiu CH; Lin PY; Chen CJ; Chavand P; Ortiz E
Int J Infect Dis; 2007 Nov; 11(6):488-95. PubMed ID: 17349809
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of antibody to Bordetella pertussis in neonates and prevalence of recent pertussis infection in pregnant women in Catalonia (Spain) in 2003 and 2013.
Plans P; Álvarez E; de Ory F; Campins M; Payà T; Balfagón P; Godoy P; Caylà J; Carreras R; Cabero L; Domínguez A;
Pediatr Infect Dis J; 2014 Nov; 33(11):1114-8. PubMed ID: 24871642
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
